Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024
Compare Balance Sheet Results of Emmessar Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
0.90
4.10
455.56%
Share Warrants & Outstandings
Total Reserve
2.71
3.14
-0.43
-13.69%
Shareholder's Funds
7.71
4.04
3.67
90.84%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
4.32
-4.32
-100.00%
Secured Loans
0.00
2.11
-2.11
-100.00%
Unsecured Loans
0.00
2.21
-2.21
-100.00%
Deferred Tax Assets / Liabilities
0.32
0.38
-0.06
-15.79%
Other Long Term Liabilities
0.59
0.00
0.59
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.13
0.00
0.13
0.00%
Total Non-Current Liabilities
1.04
4.69
-3.65
-77.83%
Current Liabilities
Trade Payables
0.00
9.52
-9.52
-100.00%
Other Current Liabilities
0.13
0.30
-0.17
-56.67%
Short Term Borrowings
0.00
6.53
-6.53
-100.00%
Short Term Provisions
0.34
0.27
0.07
25.93%
Total Current Liabilities
0.47
16.62
-16.15
-97.17%
Total Liabilities
9.22
25.35
-16.13
-63.63%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.04
10.67
-8.63
-80.88%
Less: Accumulated Depreciation
0.82
5.50
-4.68
-85.09%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.22
5.17
-3.95
-76.40%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.49
-2.49
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.59
0.36
0.23
63.89%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
0.31
-0.31
-100.00%
Total Non-Current Assets
1.81
8.33
-6.52
-78.27%
Current Assets Loans & Advances
Current Investments
0.01
0.00
0.01
0.00%
Inventories
0.12
5.86
-5.74
-97.95%
Sundry Debtors
0.02
9.71
-9.69
-99.79%
Cash and Bank
6.87
0.69
6.18
895.65%
Other Current Assets
0.09
0.74
-0.65
-87.84%
Short Term Loans and Advances
0.29
0.00
0.29
0.00%
Total Current Assets
7.41
17.02
-9.61
-56.46%
Net Current Assets (Including Current Investments)
6.93
0.40
6.53
1,632.50%
Total Current Assets Excluding Current Investments
7.40
17.02
-9.62
-56.52%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.22
25.35
-16.13
-63.63%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
10.85
-10.85
-100.00%
Book Value per share (adjusted)
15.43
43.79
-28.36
-64.76%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Annual - Investments
Investments 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Annual - Current Assets
Current Assets 7.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024
